logo

HITAP เข้าสู่ระบบ

ลืมรหัสผ่าน?

An economic evaluation of tetravalent dengue vaccine in Thailand

Home > Research Projects > Strategy 3 : HTA Research > An economic evaluation of tetravalent dengue vaccine in Thailand

Project Code

201-349-2553

Research team

Researchers

Surachai Kotirum, B.Sc. (Pharmacy), Pharm D.

Co - Researcher

Pritaporn Kingkaew, PhD.

Yot Teerawattananon, PhD.

Adun Mohara B.Pharm, M.Sc.(Health Economic)

Project Details

Strategies
Country

Project duration

Start: - 2010
End: -

Contact
[email protected]

Project Status

Validation of results - 90%

Viewer: 2348

Publish date11 December 2011 12:45

Project Summary

The objectives of this study are to identify resources used for providing tetravalent dengue vaccine to prevent dengue infection in the Thai health care settingestimate the budget impact of dengue vaccination program nationwide and to conduct economic evaluation of providing tetravalent dengue vaccine program compared with no vaccination program. The dynamic epidemiologic model will be used to obtain the incidence of asymptomatic and symptomatic dengue infections, as well as to evaluate the impact of vaccination programme to take account of the herd immunity effect from the program.  

Documents

Activity

Health Intervention and Technology Assessment Program Foundation
Head Office : 88/22 Moo 4, 6th Building, 6th Floor, Department of Health, Ministry of Public Health, Tiwanon Road, Taladkwan Subdistrict, Muang Nonthaburi District, Nonthaburi 11000, Thailand


Tel. : +662-590-4549, +662-590-4374-5
Fax : +662-590-4369
E-mail : [email protected]
Website : www.hitap.net


© Copyright - HITAP 2014
Top